896 related articles for article (PubMed ID: 22669242)
21. Pancreatic cancer-induced cachexia is Jak2-dependent in mice.
Gilabert M; Calvo E; Airoldi A; Hamidi T; Moutardier V; Turrini O; Iovanna J
J Cell Physiol; 2014 Oct; 229(10):1437-43. PubMed ID: 24648112
[TBL] [Abstract][Full Text] [Related]
22. Role of interleukin-6 in cachexia: therapeutic implications.
Narsale AA; Carson JA
Curr Opin Support Palliat Care; 2014 Dec; 8(4):321-7. PubMed ID: 25319274
[TBL] [Abstract][Full Text] [Related]
23. STAT3 in the systemic inflammation of cancer cachexia.
Zimmers TA; Fishel ML; Bonetto A
Semin Cell Dev Biol; 2016 Jun; 54():28-41. PubMed ID: 26860754
[TBL] [Abstract][Full Text] [Related]
24. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.
Daou HN
Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R296-R310. PubMed ID: 31823669
[TBL] [Abstract][Full Text] [Related]
25. Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6/STAT3/FoxO signaling pathway.
Wang Y; Sun X; Yang Q; Guo C
Phytother Res; 2023 Aug; 37(8):3380-3393. PubMed ID: 37073890
[TBL] [Abstract][Full Text] [Related]
26. Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia.
Lee JH; Kim SW; Kim JH; Kim HJ; Um J; Jung DW; Williams DR
Cells; 2021 Apr; 10(5):. PubMed ID: 33925786
[TBL] [Abstract][Full Text] [Related]
27. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
[TBL] [Abstract][Full Text] [Related]
28. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.
Zanders L; Kny M; Hahn A; Schmidt S; Wundersitz S; Todiras M; Lahmann I; Bandyopadhyay A; Wollersheim T; Kaderali L; Luft FC; Birchmeier C; Weber-Carstens S; Fielitz J
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):713-727. PubMed ID: 34821076
[TBL] [Abstract][Full Text] [Related]
29. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.
Judge SM; Deyhle MR; Neyroud D; Nosacka RL; D'Lugos AC; Cameron ME; Vohra RS; Smuder AJ; Roberts BM; Callaway CS; Underwood PW; Chrzanowski SM; Batra A; Murphy ME; Heaven JD; Walter GA; Trevino JG; Judge AR
Cancer Res; 2020 May; 80(9):1861-1874. PubMed ID: 32132110
[TBL] [Abstract][Full Text] [Related]
30. Targeting the JAK2/STAT3 Pathway-Can We Compare It to the Two Faces of the God Janus?
Jaśkiewicz A; Domoradzki T; Pająk B
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158194
[TBL] [Abstract][Full Text] [Related]
31. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
[TBL] [Abstract][Full Text] [Related]
32. Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3.
Toledo M; Penna F; Busquets S; López-Soriano FJ; Argilés JM
PLoS One; 2014; 9(12):e113931. PubMed ID: 25436606
[TBL] [Abstract][Full Text] [Related]
33. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression.
Hetzler KL; Hardee JP; Puppa MJ; Narsale AA; Sato S; Davis JM; Carson JA
Biochim Biophys Acta; 2015 May; 1852(5):816-25. PubMed ID: 25555992
[TBL] [Abstract][Full Text] [Related]
34. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
Puppa MJ; Gao S; Narsale AA; Carson JA
FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
[TBL] [Abstract][Full Text] [Related]
35. Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.
Narsale AA; Puppa MJ; Hardee JP; VanderVeen BN; Enos RT; Murphy EA; Carson JA
Oncotarget; 2016 Sep; 7(37):59482-59502. PubMed ID: 27449092
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR
BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728
[TBL] [Abstract][Full Text] [Related]
37.
Hodgson JA; Parvy JP; Yu Y; Vidal M; Cordero JB
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361081
[TBL] [Abstract][Full Text] [Related]
38. Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
Martinelli GB; Olivari D; Re Cecconi AD; Talamini L; Ottoboni L; Lecker SH; Stretch C; Baracos VE; Bathe OF; Resovi A; Giavazzi R; Cervo L; Piccirillo R
Oncogene; 2016 Dec; 35(48):6212-6222. PubMed ID: 27212031
[TBL] [Abstract][Full Text] [Related]
39. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
[TBL] [Abstract][Full Text] [Related]
40. Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting.
Shum AM; Mahendradatta T; Taylor RJ; Painter AB; Moore MM; Tsoli M; Tan TC; Clarke SJ; Robertson GR; Polly P
Aging (Albany NY); 2012 Feb; 4(2):133-43. PubMed ID: 22361433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
